SES
19.11.2021 08:52:13 CET | Business Wire | Press release
Residents of two remote Kazakhstan villages can now benefit from unprecedented Internet speeds via satellite-enabled Wi-Fi, through a network set up for 30 days by the leading global content connectivity solutions provider SES. The demo is implemented in cooperation with the Republican Center for Space Communications (RCSC ), a subsidiary of the Ministry of Digital Development, Innovations and Aerospace Industry and AsiaNetCom, a Kazakhstan-based connectivity provider. During the demonstration, the companies have achieved 380Mbps downlink and 120Mbps uplink via SES’s O3b satellite constellation, the highest speed ever recorded in Kazakhstan via satellite.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211118006475/en/
The demo is done in the framework of the country’s national project called “Technological breakthrough via digitalisation, science and innovation”, that aims to bridge the digital divide and bring the benefits of high-performance communication networks for healthcare, businesses, local administrations, education and more.
As part of the collaboration agreement between SES and RCSC signed earlier this year, the test demonstrates the benefits of SES’s Medium Earth Orbit (MEO) networks and its upcoming second-generation O3b mPOWER communications system.
The current demo network is leveraging SES’s first-generation O3b satellites to connect an RCSC teleport located in Kokterek with the villages of Akterek and Beriktas for high-speed Internet access.
“Kazakhstan has already made progress in providing Internet connectivity to the population. However, there are still remote villages where it is impossible to deliver a network using radio relay communications or through cable connection. In those circumstances, we decided to use satellite constellations. This will allow us to expand our coverage and provide broadband Internet connection to the population of Kazakhstan”, said Bagdat Mussin, Minister of Digital Development, Innovations and Aerospace Industry (MDDIAI RK).
“The premise of national project “Technological breakthrough via digitalisation, science and innovation” is to bring the same quality of life and opportunities afforded by Internet access to every citizen of the country, wherever they live - in Nur-Sultan or in a remote mountain village. In some cases, the use of terrestrial networks is economically impractical, and we are considering the opportunities to implement innovative satellite technology to provide high-speed connectivity in those remote villages. The demo gives us an opportunity to explore the possibilities of further scaling”, said Malik Zhuiriktayev, Chairman of the Board of JSC RCSC.
“We are very excited to participate in this project, which aims to digitalise and to improve all spheres of life and economy in the country. Today in collaboration with our partners RCSC and AsiaNetCom, we have demonstrated the unrivalled performance of our innovative and proven MEO network by connecting rural Kazakhstan”, said Sandeep Jalan, Chief Financial Officer of SES. “When operational next year, our second-generation MEO system, O3b mPOWER, will further multiply the capacity delivered and bandwidth. In addition, it will deliver significantly higher speeds flexibly, catering to the increasing needs from governments, enterprises and mobile operators.”
Follow us on:
Twitter
Facebook
YouTube
LinkedIn
Instagram
Read our Blogs >
Visit the Media Gallery >
About SES
SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries over 8,500 channels and has an unparalleled reach of 361 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com .
About RCSC
Joint Stock Company "Republican Center for Space Communication" was established by the Decree of the Government of the Republic of Kazakhstan in December 2003 on behalf of the First President of the Republic of Kazakhstan.
JSC "RCSC" is a subordinate enterprise of the Aerospace Committee of the Ministry of Digital Development, Innovation and Aerospace Industry of the Republic of Kazakhstan, the National Operator of the Space Communication System of Kazakhstan.
The Republican Center for Space Communications provides services for the provision of the transponder capacity of spacecraft (SC) of the KazSat series, monitoring of fixed satellite communication channels in the Ku-band on a geostationary arc from 13 to 130 E, as well as using the capabilities of the Teleport based on the Reserve ground-based spacecraft control complex and communication monitoring systems.
The resources of the KazSat series spacecraft made it possible to implement efficient and reliable satellite communication channels in the Republic of Kazakhstan. Spacecraft of the KazSat series, operated by RCKS JSC, provide great opportunities for telecommunications operators in Kazakhstan, national companies and holdings, government agencies and private companies for organizing digital TV and radio broadcasting (HD, DTH, IPTV), broadband Internet access, data transmission and creation of corporate satellite communication networks of various topologies.
Currently, JSC "RCSC" is one of the leading enterprises in the implementation of activities on communications in the telecommunications market of Kazakhstan.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211118006475/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom